Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine manipulation of NMDA-dependent learning in conditioned nocebo pain and itch
NL-OMON49103Active, not recruiting
- Sponsor
- Leiden University
- Start
- Feb 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing D-cycloserine with Placebo (2 arms). Primary endpoint: Primary nocebo effect magnitude on pain and itch. Started Feb 2021; status: active, not recruiting.
02
Drugs
d-cycloserine
Beyond the preview
Go deeper on NL-OMON49103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49103.